Pfizer Agrees to $486M Settlement with Shareholders Over Concealing Drug Risks

By Andrew G. Simpson Pfizer Inc. on Tuesday said it has reached a $486 million settlement of litigation accusing it of causing big losses for shareholders by concealing safety risks associated with its Celebrex and Bextra pain-relieving drugs. The accord is subject to negotiation … Read More

Read more here:: Insurance Journal

      

Contact Us

Lean on GSR's 50+ years of experience for all your Insurance Recruiting needs.